Form4insider filings, from the source

SEC Form 4 · accession 0001209191-16-089112

MELINTA THERAPEUTICS, INC. /NEW/ · MLNT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
David W. Oldach
Officer — Chief Medical Officer
Period of report
Jan 1, 2016
Accepted (ET)
Jan 5, 2016 · 5:35 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001461993

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stockholding———1,100D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (Right to Buy)F7$31.13Jan 1, 2016A45,893A—Dec 31, 2025Common Stock45,89345,893D
Employee Stock Option (Right to Buy)F1$23.51holding————Dec 31, 2024Common Stock23,00023,000D
Employee Stock Option (Right to Buy)F2$13.10holding————Jan 7, 2024Common Stock7,5007,500D
Employee Stock Option (Right to Buy)F3$6.64holding————Mar 6, 2023Common Stock10,00010,000D
Employee Stock Option (Right to Buy)F4$6.63holding————Jan 17, 2023Common Stock14,08714,087D
Employee Stock Option (Right to Buy)F5$7.47holding————Mar 20, 2022Common Stock20,00020,000D
Employee Stock Option (Right to Buy)F6$2.28holding————Feb 28, 2021Common Stock8,22218,125D
Employee Stock Option (Right to Buy)F6$2.28holding————Feb 28, 2021Common Stock1,77816,347D

Explanation of responses